Evidence map›Paper›PMID 40815664›Full record

ArticleScience advances2025

Asymmetric catalytic reductive transformation of S(VI) to S(IV) for modular access to S(IV)-stereogenic sulfilimine derivatives.

Minghong Liao, Shiqing Huang, Qiang Xiong, Zhongfu Luo, Sha Zhao, Taiyou Xu, Xingxing Wu

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Minghong LiaoState Key Laboratory of Green Pesticide, Center for Research and Development of Fine Chemicals, Guizhou University, Huaxi District, Guiyang 550025, P. R. China.ORCID 0009-0005-4104-8515
Shiqing HuangSchool of Chemistry, Chemical Engineering, and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore.ORCID 0000-0002-6377-368X
Qiang XiongState Key Laboratory of Green Pesticide, Center for Research and Development of Fine Chemicals, Guizhou University, Huaxi District, Guiyang 550025, P. R. China.
Zhongfu LuoState Key Laboratory of Green Pesticide, Center for Research and Development of Fine Chemicals, Guizhou University, Huaxi District, Guiyang 550025, P. R. China.
Sha ZhaoState Key Laboratory of Green Pesticide, Center for Research and Development of Fine Chemicals, Guizhou University, Huaxi District, Guiyang 550025, P. R. China.
Taiyou XuState Key Laboratory of Green Pesticide, Center for Research and Development of Fine Chemicals, Guizhou University, Huaxi District, Guiyang 550025, P. R. China.
Xingxing WuState Key Laboratory of Green Pesticide, Center for Research and Development of Fine Chemicals, Guizhou University, Huaxi District, Guiyang 550025, P. R. China.ORCID 0000-0002-6281-243X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfur plays a pivotal role across diverse fields owing to its distinctive chemical and biological properties, thereby propelling the development of stereoselective synthesis of enantioenriched S(IV)-stereogenic scaffolds. While oxidative strategies for generating S-chiral frameworks have witnessed emerging development, the catalytic reduction of S(VI) species to furnish enantioenriched S(IV) scaffolds remains largely overlooked. Herein, we present an enantioselective catalytic method to access S(IV)-stereogenic sulfinimidate ester scaffolds through a distinct catalytic asymmetric formal reductive transformation of S(VI)-sulfonimidoyl chlorides. Using a naturally occurring, cost-effective quinine organocatalyst, we achieved high enantioselectivity in chiral sulfinimidate ester formation via asymmetric S─O bond formation. The catalyst plays dual critical roles, facilitating both the reduction of S(VI) substrates and the catalytic stereoselective formation of S─O bonds. This approach offers a rapid and efficient pathway to sulfinimidate esters, which serves as versatile intermediates for subsequent modular access to diverse S-chiral sulfilimine and sulfinamidine scaffolds, with promising applications in agrochemical and pharmaceutical discovery.

Identifiers

PMID40815664
PMCPMC12356258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.